ikfe GmbH

For profitWebsite ↗

Also known as: ikfe-CRO GmbH | Ikfe GmbH | ikfe GmbH, Institut for Klinische Forschung und Entwicklung, Parcusstr. 8, 55116 Mainz, Germany | Marcus Borchert

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 1, 2008

Last known activity

Jan 1, 2013

Timeline

2000s

Jan 1, 2008
ikfe GmbH— Founded

Drugs by trial phase (12 distinct, 9 trials)

Phase 4 (11 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

cebranopadol

Indications

Studied for

Recent trials (17)

NCT02376075CollaboratorPhase 3Jan 1, 2013
NCT02376075Lead sponsorPhase 3Jan 1, 2013
NCT01547104CollaboratorPhase 4Apr 1, 2012
NCT01547104Lead sponsorPhase 4Apr 1, 2012
NCT01547104Overall official - principal investigatorPhase 4Apr 1, 2012
NCT01547104Sponsor investigatorPhase 4Apr 1, 2012
NCT01565096Lead sponsorPhase 4Nov 1, 2011
NCT01565096Overall official - principal investigatorPhase 4Nov 1, 2011
NCT01500850Overall official - principal investigatorPhase 4Oct 1, 2011
NCT01500850Lead sponsorPhase 4Oct 1, 2011
NCT01417897Reponsible party - principal investigatorPhase 4Sep 1, 2011
NCT01417897Lead sponsorPhase 4Sep 1, 2011
NCT01347671Overall official - principal investigatorPhase 2May 1, 2011
NCT01208012Overall official - principal investigatorPhase 4Apr 1, 2010
NCT01208012Lead sponsorPhase 4Apr 1, 2010

Details

Founded: Mainz, DE Jan 1, 2008
Last known activity: Jan 1, 2013